Thai FDA seeks to tighten controls on GLP-1 “slimming pens”, proposing special controlled-drug status
Thailand’s Food and Drug Administration (FDA) warns that widespread use promoted on social media — including self-adjusted dosing — is leading to ongoing misuse.
